Halberd Corp (HALB)

[EHRjunkie]

A few months ago Halberd issued a press release about a third granted US patent (11186629) treating Cockayne Syndrome (CS), but it attracted little attention. Halberd (licensee MARV Enterprises)already owned 2 granted US patents to protect its extracorporeal treatment, but this third patent is about treating a neurodegenerative disease in an "out-of-the-body" treatment. All experimentation at ASU & YSU at the moment is about treating other neurodegenerative diseases like Alzheimer's, PTSD, CTE, ALS, TBI, MS etc and numerous provisional patent applications have been filed to keep all competition out. Now they have their patent treating CS in the patented extracorporeal treatment using antibodies, they will surely get the patents for treating other diseases the same way. Nobody realises the enormity of the CS patent, but it's the first proof they have completely protected their IP. And mind you, using the antibody/antigen/metallic-moiety/complex in combination with RF/Laser has been protected through prov. patent applications as well.

HALB almost completed the preliminary testing at ASU/YSU and January '22 is key. They need funding/partners to start animal testing. I have no doubt they will succeed. Read some scientific papers on internet by researchers who tried to control inflammatory cytokine levels in cerebral spinal fluid. All total failures. Imagine what happens when dr. Chen from ASU writes his scientific article for publication. Here it is:

Treatment method for Cockayne syndrome
Patent number: 11186629

Abstract: Disclosed is a method for treating of Cockayne Syndrome (CS). Specifically, the invention pertains to a method for the extracorporeal treatment of a body fluid by removing the body fluid from a living body diseased with CS, and applying a targeted antibody either a mammalian target of rapamycin (mTOR) antigen or a death-associated protein 1 (DAP1) in a bodily fluid such as blood, creating an antibody-antigen complex, removing antibody-antigen complex from the bodily fluid, and returning the purified bodily fluid to the CS patient.
Type: Grant
Filed: February 5, 2020
Date of Patent: November 30, 2021
Assignee: HALBERD CORPORATION
Inventor: Mitchell S. Felder

https://patents.justia.com/search?q=mitchell+s.+felder&page=2

Enjoy Christmas and see you in the new year, Bill